UPDATE : Tuesday, August 11, 2020
Hanmi Science, Bioapp to start full-scale development of Green bio-based COVID-19 vaccine by Lee Han-soo 2020-07-14 14:58
LSK Global PS chosen as CRO of IVI's Covid-19 vaccine trials by Lee Han-soo 2020-07-13 15:48
‘Remdesivir cut death risk by 62% in severely ill Covid-19 patients’ by Kim Yun-mi 2020-07-13 14:44
Regulator OKs Samyang’s breast cancer treatment by Lee Han-soo 2020-07-13 14:38
Multinational drugmakers seek to form new trade union by Kim Yun-mi 2020-07-13 11:44
Ministry OKs Dongkook's P3 trial into benign prostatic hyperplasia treatment by Lee Han-soo 2020-07-10 16:54
Court rejects Medytox's request not to revoke license of Medytoxin by Lee Han-soo 2020-07-10 14:59
'Xolair’s reimbursement will change treatment paradigm for asthma patients' by Lee Han-soo 2020-07-09 18:11
Drugmakers appeal limited insurance benefit for dementia drug choline alfoscerate by Kim Chan-hyuk 2020-07-09 12:52
‘Hypertension drug Opsumit enhances right ventricle function’ by Shim Hyun-tai 2020-07-08 16:59
Crystal Genomics confirms safety of super-bacteria antibiotic candidate by Lee Han-soo 2020-07-08 16:58
‘Study results on MSD’s Keytruda very disappointing’ by Kim Yun-mi 2020-07-07 16:43
ITC ruling gives Medytox upper hand in BTX strain dispute by Lee Han-soo 2020-07-07 11:47
Daewoong to conduct P1 trial of Covid-19 treatment in Indonesia by Lee Han-soo 2020-07-06 16:52
Regulator OKs Janssen's multiple myeloma treatment by Lee Han-soo 2020-07-06 15:48
Experts showed mixed preferences between 2 diabetes treatments by Kim Yun-mi 2020-07-06 14:20
[News Focus] Who will win BTX strain dispute – Daewoong or Medytox? by Kim Chan-hyuk 2020-07-06 11:50
Crystal Genomics to start P2 trial of Covid-19 treatment by Lee Han-soo 2020-07-02 18:07
Boryung finds cancer drug has antiviral effect on Covid-19 by Shim Hyun-tai 2020-07-02 18:07
Heliximith unveiled how HX109 inhibits prostate hyperplasia by Lee Han-soo 2020-07-02 15:03
Back to Top